These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9067497)

  • 1. Characterization of the humoral immune response in heparin-induced thrombocytopenia.
    Suh JS; Malik MI; Aster RH; Visentin GP
    Am J Hematol; 1997 Mar; 54(3):196-201. PubMed ID: 9067497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
    Visentin GP; Ford SE; Scott JP; Aster RH
    J Clin Invest; 1994 Jan; 93(1):81-8. PubMed ID: 8282825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.
    Untch B; Ahmad S; Jeske WP; Messmore HL; Hoppensteadt DA; Walenga JM; Lietz H; Fareed J
    Thromb Res; 2002 Jan; 105(2):117-23. PubMed ID: 11958801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc gamma RIIA H/R 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis.
    Arepally G; McKenzie SE; Jiang XM; Poncz M; Cines DB
    Blood; 1997 Jan; 89(2):370-5. PubMed ID: 9002937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia.
    Amiral J; Wolf M; Fischer A; Boyer-Neumann C; Vissac A; Meyer D
    Br J Haematol; 1996 Mar; 92(4):954-9. PubMed ID: 8616093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes.
    Visentin GP; Malik M; Cyganiak KA; Aster RH
    J Lab Clin Med; 1996 Oct; 128(4):376-83. PubMed ID: 8833886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?
    Warkentin TE; Sheppard JA; Moore JC; Moore KM; Sigouin CS; Kelton JG
    J Lab Clin Med; 2005 Dec; 146(6):341-6. PubMed ID: 16310517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia.
    Denomme GA; Warkentin TE; Horsewood P; Sheppard JA; Warner MN; Kelton JG
    J Lab Clin Med; 1997 Sep; 130(3):278-84. PubMed ID: 9341987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
    Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
    Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations of the immunoglobulin subtype transformation of anti-heparin-platelet factor 4 antibodies during treatment with a low-molecular-weight heparin (clivarin) in orthopedic patients.
    Ahmad S; Bacher HP; Lassen MR; Hoppensteadt DA; Leitz H; Misselwitz F; Walenga JM; Fareed J
    Arch Pathol Lab Med; 2003 May; 127(5):584-8. PubMed ID: 12708902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
    Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
    Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
    Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
    Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Platelet factor 4, target of anti-heparin antibodies: application to biological diagnosis of heparin-induced thrombopenia].
    Amiral J
    Ann Med Interne (Paris); 1997; 148(2):142-9. PubMed ID: 9238439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
    Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
    Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia.
    Alberio L; Kimmerle S; Baumann A; Taleghani BM; Biasiutti FD; Lämmle B
    Am J Med; 2003 May; 114(7):528-36. PubMed ID: 12753876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin.
    Amiral J; Peynaud-Debayle E; Wolf M; Bridey F; Vissac AM; Meyer D
    Am J Hematol; 1996 Jun; 52(2):90-5. PubMed ID: 8638647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role for mouse marginal zone B cells in PF4/heparin antibody production.
    Zheng Y; Yu M; Podd A; Yuan L; Newman DK; Wen R; Arepally G; Wang D
    Blood; 2013 Apr; 121(17):3484-92. PubMed ID: 23460609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional heterogeneity of antiheparin-platelet factor 4 antibodies: implications in the pathogenesis of the HIT syndrome.
    Ahmad S; Walenga JM; Jeske WP; Cella G; Fareed J
    Clin Appl Thromb Hemost; 1999 Oct; 5 Suppl 1():S32-7. PubMed ID: 10726034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
    Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
    Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the immune response in heparin-induced thrombocytopenia.
    Warkentin TE; Sheppard JA; Moore JC; Cook RJ; Kelton JG
    Blood; 2009 May; 113(20):4963-9. PubMed ID: 19144981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.